• 1998

Company Description

Angion Biomedica is a clinical stage organ restoration biopharmaceutical company focused on renal disease.

Angion Biomedica is a clinical stage organ restoration biopharmaceutical company focused on renal disease. Its investigational drug BB3 is entering phase 3 for delayed graft function following kidney transplant and phase 2 for acute kidney injury following open heart surgery using cardiopulmonary bypass. Angion Biomedica was founded in 1998 and is based in Uniondale, New York.

  • Manufacturer:

    Science and Engineering
  • Formed:

    1998
  • Company Website:

  • Company E-mail:

  • Company Address:

    51 Charles Lindbergh Boulevard
    Uniondale, NY
    United States